The global artificial intelligence in precision medicine market size is estimated to reach USD 14.53 billion by 2030, registering to grow at a CAGR of 36.23% from 2025 to 2030 according to a new report by Grand View Research, Inc. The increasing demand for digital healthcare and clinical health records drives the market for AI in precision medicine. The demand for Electronic Medical Records (EMRs) in healthcare is considerably growing due to advancements in healthcare IT. One of the important applications for delivering timely medical services digitally is Electronic Medical Records (EMRs) accessed, managed, and generated by authorized workers inside a healthcare institution. Furthermore, the usage of EMRs is expanding quickly, necessitating greater development and easier applications, which is accomplished through the medical industry’s cutting-edge IT sector.
According to the Henry J. Kaiser Family Foundation, a nonprofit healthcare organization located in the U.S., 45% of U.S. residents believe that have enhanced the quality of care in the medical industry. The increasing popularity of wearables in precision medicine is revolutionizing healthcare and empowering individuals to manage their well-being actively. Smartwatches, fitness trackers, and biosensors are among the wearable devices that are in high demand. These devices offer real-time data collection on various health indicators, making them invaluable tools. Wearables provide a wealth of information by continuously monitoring vital signs, physical activity, sleep patterns, and other biometric data.
This comprehensive understanding of an individual's health status allows healthcare providers to personalize treatment plans and interventions to meet their needs. The COVID-19 pandemic has accelerated the adoption of AI in the healthcare sector. AI applications have significantly improved various healthcare services, from precision medicine and population health to chronic disease management and medical imaging. The utilization of AI in managing COVID-19 has played a key role in expanding the market growth. An example is the development of a COVID-19 mortality risk calculator by a Johns Hopkins School of Public Health team, which utilized AI to guide public health initiatives and allocate resources for prevention, such as N-95 masks.
Request a free sample copy or view report summary: Artificial Intelligence In Precision Medicine Market Report
Software had a significant revenue share of 41.86% in 2024 and is expected to grow at the fastest CAGR during the forecast period.
Based on technology, the deep learning segment dominated the market with a revenue share of 33.60% in 2024.
Oncology had a significant revenue share of 30.25% in 2024.
Grand View Research has segmented the global artificial intelligence in precision medicine market based on component, technology, therapeutic applications, and region:
Artificial Intelligence In Precision Medicine Component Outlook (Revenue, USD Million, 2018 - 2030)
Software
Hardware
Services
Artificial Intelligence In Precision Medicine Technology Outlook (Revenue, USD Million, 2018 - 2030)
Deep Learning
Querying Method
Natural language processing
Context aware processing
Artificial Intelligence In Precision Medicine Therapeutic Application Outlook (Revenue, USD Million, 2018 - 2030)
Oncology
Cardiology
Neurology
Respiratory
Others
Artificial Intelligence In Precision Medicine Regional Outlook (Revenue, USD Million, 2018 - 2030)
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Spain
Norway
Denmark
Sweden
Asia Pacific
Japan
China
India
Australia
South Korea
Thailand
Latin America
Brazil
Argentina
Middle East and Africa (MEA)
South Africa
Saudi Arabia
UAE
Kuwait
List of Key Players in Artificial Intelligence In Precision Medicine Market
BioXcel Therapeutics Inc.
Sanofi
NVIDIA Corporation
Alphabet Inc. (Google Inc.)
IBM
Microsoft
Intel Corp.
AstraZeneca plc
GE HealthCare
Enlitic, Inc.
"The quality of research they have done for us has been excellent..."